So, there is a complex hormonal and metabolic effect of obesity, weight alterations, age and hormones that play a role in the acne development of women on these medications that needs more research. According to the authors interpretation of previous studies taken with their findings, the hyperandrogenic state of women with obesity may heighten their response to GLP-1 receptor agonists
doi:10.1111/dom.15184 Pratt E, Ma X, Liu R, et al
Description This vial contains a 1:1 blend of Sema (GLP-1 Agonist) and Cagri (Amylin Analogue)
Within this FM 2.0 lens, GLP-1 therapy becomes a catalyst, not a crutch
Retatrutide injection compared to other GLP-1 peptides If you are considering retatrutide or transitioning from another GLP-1 peptide, understanding the injection differences helps set expectations and adapt your technique